As of 2025-07-01, the Relative Valuation of XORTX Therapeutics Inc (XRX.CN) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.90 CAD, the upside of XORTX Therapeutics Inc based on Relative Valuation is -101.8%.
The range of the Relative Valuation is (0.03) - (1.92) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 10.3x | 0.1x |
| Forward P/E multiples | 0.1x - 5.7x | 0.1x |
| Fair Price | (0.03) - (1.92) | (0.03) |
| Upside | -101.4% - -201.2% | -101.8% |
| Date | P/E |